This inventor holds 1 USPTO granted patent. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Lavanya Andiappan: Innovator in Pharmaceutical Chemistry
Introduction
Lavanya Andiappan is a notable inventor based in Chennai, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as phosphodiesterase inhibitors. Her work is crucial in addressing various allergic and inflammatory diseases.
Latest Patents
Lavanya holds a patent for "Heterocyclic compounds as phosphodiesterase inhibitors." This patent includes compounds of the formula (I), along with their derivatives, analogs, and various forms. These compounds are specifically phosphodiesterase type 4 (PDE4) inhibitors, which are beneficial in treating a range of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and rheumatoid arthritis, among others.
Career Highlights
Lavanya is currently associated with Orchid Chemicals & Pharmaceuticals Limited, where she applies her expertise in pharmaceutical research and development. Her innovative work has the potential to improve treatment options for patients suffering from chronic inflammatory diseases.
Collaborations
Lavanya collaborates with esteemed colleagues, including Gopalan Balasubramanian and Sukunath Narayanan, to further advance her research and development efforts in the pharmaceutical sector.
Conclusion
Lavanya Andiappan's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her work in developing PDE4 inhibitors is a testament to her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile